Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
MUFG Intime India Private Limited, the Registrar and Transfer Agent for Beta Drugs Limited, has issued a compliance certificate confirming that securities received for dematerialisation during Q4 FY2026 (quarter ended 31st March 2026) were properly processed. The certificate confirms that dematerialised securities have been listed on the relevant stock exchanges and that physical share certificates were mutilated and cancelled after verification. The depositories have been substituted as registered owners in the share register within prescribed timelines.
This is a routine regulatory compliance filing confirming proper handling of dematerialisation requests. It carries no direct impact on the stock price or shareholder value and does not indicate any operational concerns.